Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gene therapy refers to the introduction of exogenous normal genes into target cells to correct or compensate for diseases caused by defective and abnormal genes in order to achieve therapeutic goals.
In recent years, gene therapy has been used with increased frequency to treat a variety of rare and incurable diseases, such as cancer and genetic disorders. Increased funding for cellular gene therapy companies in European countries such as the UK is expected to drive the European market at a considerable growth rate. Moreover, European companies are committed to expand product distribution globally by obtaining approvals from several regulatory bodies. China is recognized as a global focus for the development of new therapies. In the current scenario, the number of ongoing clinical trials for gene therapies in China has surpassed the number of trials in the US. The Asia-Pacific gene therapy market is also expected to grow.
Gene therapy can provide a fundamental solution to many difficult conditions such as cancer, and with the increasing research in biotechnology, more gene therapies will be found, which is expected to drive the gene therapy market.
Gene Therapy market report explains the definition, types, applications, major countries, and major players of the Gene Therapy market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Dimension Therapeutics
Celladon
Vical
Avalanche Bio
Spark Therapeutics
Sangamo
Advantagene
By Type:
Lentivirus
AAV
Retrovirus & Gammaretrovirus
Modified Herpes Simplex Virus
Adenovirus
Non-viral Plasmid Vector
By End-User:
Acute Lymphoblastic Leukemia (ALL)
Inherited Retinal Disease
Large B-cell Lymphoma
ADA-SCID
Melanoma (Lesions)
Beta-Thalassemia Major/SCD
Head & Neck Squamous Cell Carcinoma
Peripheral Arterial Disease
Spinal Muscular Atrophy (SMA)
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Gene Therapy Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Gene Therapy Outlook to 2028- Original Forecasts
-
2.2 Gene Therapy Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Gene Therapy Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Gene Therapy Market- Recent Developments
-
6.1 Gene Therapy Market News and Developments
-
6.2 Gene Therapy Market Deals Landscape
7 Gene Therapy Raw Materials and Cost Structure Analysis
-
7.1 Gene Therapy Key Raw Materials
-
7.2 Gene Therapy Price Trend of Key Raw Materials
-
7.3 Gene Therapy Key Suppliers of Raw Materials
-
7.4 Gene Therapy Market Concentration Rate of Raw Materials
-
7.5 Gene Therapy Cost Structure Analysis
-
7.5.1 Gene Therapy Raw Materials Analysis
-
7.5.2 Gene Therapy Labor Cost Analysis
-
7.5.3 Gene Therapy Manufacturing Expenses Analysis
8 Global Gene Therapy Import and Export Analysis (Top 10 Countries)
-
8.1 Global Gene Therapy Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Gene Therapy Export by Region (Top 10 Countries) (2017-2028)
9 Global Gene Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Gene Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Lentivirus Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AAV Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Retrovirus & Gammaretrovirus Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Modified Herpes Simplex Virus Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Adenovirus Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Non-viral Plasmid Vector Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Acute Lymphoblastic Leukemia (ALL) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Inherited Retinal Disease Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Large B-cell Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global ADA-SCID Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Melanoma (Lesions) Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Beta-Thalassemia Major/SCD Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Head & Neck Squamous Cell Carcinoma Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Peripheral Arterial Disease Consumption and Growth Rate (2017-2022)
-
9.2.9 Global Spinal Muscular Atrophy (SMA) Consumption and Growth Rate (2017-2022)
-
9.2.10 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Gene Therapy Market Analysis and Outlook till 2022
-
10.1 Global Gene Therapy Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Gene Therapy Consumption (2017-2022)
-
10.2.2 Canada Gene Therapy Consumption (2017-2022)
-
10.2.3 Mexico Gene Therapy Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Gene Therapy Consumption (2017-2022)
-
10.3.2 UK Gene Therapy Consumption (2017-2022)
-
10.3.3 Spain Gene Therapy Consumption (2017-2022)
-
10.3.4 Belgium Gene Therapy Consumption (2017-2022)
-
10.3.5 France Gene Therapy Consumption (2017-2022)
-
10.3.6 Italy Gene Therapy Consumption (2017-2022)
-
10.3.7 Denmark Gene Therapy Consumption (2017-2022)
-
10.3.8 Finland Gene Therapy Consumption (2017-2022)
-
10.3.9 Norway Gene Therapy Consumption (2017-2022)
-
10.3.10 Sweden Gene Therapy Consumption (2017-2022)
-
10.3.11 Poland Gene Therapy Consumption (2017-2022)
-
10.3.12 Russia Gene Therapy Consumption (2017-2022)
-
10.3.13 Turkey Gene Therapy Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Gene Therapy Consumption (2017-2022)
-
10.4.2 Japan Gene Therapy Consumption (2017-2022)
-
10.4.3 India Gene Therapy Consumption (2017-2022)
-
10.4.4 South Korea Gene Therapy Consumption (2017-2022)
-
10.4.5 Pakistan Gene Therapy Consumption (2017-2022)
-
10.4.6 Bangladesh Gene Therapy Consumption (2017-2022)
-
10.4.7 Indonesia Gene Therapy Consumption (2017-2022)
-
10.4.8 Thailand Gene Therapy Consumption (2017-2022)
-
10.4.9 Singapore Gene Therapy Consumption (2017-2022)
-
10.4.10 Malaysia Gene Therapy Consumption (2017-2022)
-
10.4.11 Philippines Gene Therapy Consumption (2017-2022)
-
10.4.12 Vietnam Gene Therapy Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Gene Therapy Consumption (2017-2022)
-
10.5.2 Colombia Gene Therapy Consumption (2017-2022)
-
10.5.3 Chile Gene Therapy Consumption (2017-2022)
-
10.5.4 Argentina Gene Therapy Consumption (2017-2022)
-
10.5.5 Venezuela Gene Therapy Consumption (2017-2022)
-
10.5.6 Peru Gene Therapy Consumption (2017-2022)
-
10.5.7 Puerto Rico Gene Therapy Consumption (2017-2022)
-
10.5.8 Ecuador Gene Therapy Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Gene Therapy Consumption (2017-2022)
-
10.6.2 Kuwait Gene Therapy Consumption (2017-2022)
-
10.6.3 Oman Gene Therapy Consumption (2017-2022)
-
10.6.4 Qatar Gene Therapy Consumption (2017-2022)
-
10.6.5 Saudi Arabia Gene Therapy Consumption (2017-2022)
-
10.6.6 United Arab Emirates Gene Therapy Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Gene Therapy Consumption (2017-2022)
-
10.7.2 South Africa Gene Therapy Consumption (2017-2022)
-
10.7.3 Egypt Gene Therapy Consumption (2017-2022)
-
10.7.4 Algeria Gene Therapy Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Gene Therapy Consumption (2017-2022)
-
10.8.2 New Zealand Gene Therapy Consumption (2017-2022)
11 Global Gene Therapy Competitive Analysis
-
11.1 Dimension Therapeutics
-
11.1.1 Dimension Therapeutics Company Details
-
11.1.2 Dimension Therapeutics Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Dimension Therapeutics Gene Therapy Main Business and Markets Served
-
11.1.4 Dimension Therapeutics Gene Therapy Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Celladon
-
11.2.1 Celladon Company Details
-
11.2.2 Celladon Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Celladon Gene Therapy Main Business and Markets Served
-
11.2.4 Celladon Gene Therapy Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Vical
-
11.3.1 Vical Company Details
-
11.3.2 Vical Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Vical Gene Therapy Main Business and Markets Served
-
11.3.4 Vical Gene Therapy Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Avalanche Bio
-
11.4.1 Avalanche Bio Company Details
-
11.4.2 Avalanche Bio Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Avalanche Bio Gene Therapy Main Business and Markets Served
-
11.4.4 Avalanche Bio Gene Therapy Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Spark Therapeutics
-
11.5.1 Spark Therapeutics Company Details
-
11.5.2 Spark Therapeutics Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Spark Therapeutics Gene Therapy Main Business and Markets Served
-
11.5.4 Spark Therapeutics Gene Therapy Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Sangamo
-
11.6.1 Sangamo Company Details
-
11.6.2 Sangamo Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Sangamo Gene Therapy Main Business and Markets Served
-
11.6.4 Sangamo Gene Therapy Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Advantagene
-
11.7.1 Advantagene Company Details
-
11.7.2 Advantagene Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Advantagene Gene Therapy Main Business and Markets Served
-
11.7.4 Advantagene Gene Therapy Product Portfolio
-
11.7.5 Recent Research and Development Strategies
12 Global Gene Therapy Market Outlook by Types and Applications to 2028
-
12.1 Global Gene Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Lentivirus Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global AAV Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Retrovirus & Gammaretrovirus Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Modified Herpes Simplex Virus Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Adenovirus Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Non-viral Plasmid Vector Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Gene Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Acute Lymphoblastic Leukemia (ALL) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Inherited Retinal Disease Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Large B-cell Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global ADA-SCID Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Melanoma (Lesions) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Beta-Thalassemia Major/SCD Consumption Forecast and Growth Rate (2022-2028)
-
12.2.7 Global Head & Neck Squamous Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
12.2.8 Global Peripheral Arterial Disease Consumption Forecast and Growth Rate (2022-2028)
-
12.2.9 Global Spinal Muscular Atrophy (SMA) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.10 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Gene Therapy Market Analysis and Outlook to 2028
-
13.1 Global Gene Therapy Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Gene Therapy Consumption Forecast (2022-2028)
-
13.2.2 Canada Gene Therapy Consumption Forecast (2022-2028)
-
13.2.3 Mexico Gene Therapy Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Gene Therapy Consumption Forecast (2022-2028)
-
13.3.2 UK Gene Therapy Consumption Forecast (2022-2028)
-
13.3.3 Spain Gene Therapy Consumption Forecast (2022-2028)
-
13.3.4 Belgium Gene Therapy Consumption Forecast (2022-2028)
-
13.3.5 France Gene Therapy Consumption Forecast (2022-2028)
-
13.3.6 Italy Gene Therapy Consumption Forecast (2022-2028)
-
13.3.7 Denmark Gene Therapy Consumption Forecast (2022-2028)
-
13.3.8 Finland Gene Therapy Consumption Forecast (2022-2028)
-
13.3.9 Norway Gene Therapy Consumption Forecast (2022-2028)
-
13.3.10 Sweden Gene Therapy Consumption Forecast (2022-2028)
-
13.3.11 Poland Gene Therapy Consumption Forecast (2022-2028)
-
13.3.12 Russia Gene Therapy Consumption Forecast (2022-2028)
-
13.3.13 Turkey Gene Therapy Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Gene Therapy Consumption Forecast (2022-2028)
-
13.4.2 Japan Gene Therapy Consumption Forecast (2022-2028)
-
13.4.3 India Gene Therapy Consumption Forecast (2022-2028)
-
13.4.4 South Korea Gene Therapy Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Gene Therapy Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Gene Therapy Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Gene Therapy Consumption Forecast (2022-2028)
-
13.4.8 Thailand Gene Therapy Consumption Forecast (2022-2028)
-
13.4.9 Singapore Gene Therapy Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Gene Therapy Consumption Forecast (2022-2028)
-
13.4.11 Philippines Gene Therapy Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Gene Therapy Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Gene Therapy Consumption Forecast (2022-2028)
-
13.5.2 Colombia Gene Therapy Consumption Forecast (2022-2028)
-
13.5.3 Chile Gene Therapy Consumption Forecast (2022-2028)
-
13.5.4 Argentina Gene Therapy Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Gene Therapy Consumption Forecast (2022-2028)
-
13.5.6 Peru Gene Therapy Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Gene Therapy Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Gene Therapy Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Gene Therapy Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Gene Therapy Consumption Forecast (2022-2028)
-
13.6.3 Oman Gene Therapy Consumption Forecast (2022-2028)
-
13.6.4 Qatar Gene Therapy Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Gene Therapy Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Gene Therapy Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Gene Therapy Consumption Forecast (2022-2028)
-
13.7.2 South Africa Gene Therapy Consumption Forecast (2022-2028)
-
13.7.3 Egypt Gene Therapy Consumption Forecast (2022-2028)
-
13.7.4 Algeria Gene Therapy Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Gene Therapy Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Gene Therapy Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Gene Therapy
-
Figure of Gene Therapy Picture
-
Table Global Gene Therapy Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Gene Therapy Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Lentivirus Consumption and Growth Rate (2017-2022)
-
Figure Global AAV Consumption and Growth Rate (2017-2022)
-
Figure Global Retrovirus & Gammaretrovirus Consumption and Growth Rate (2017-2022)
-
Figure Global Modified Herpes Simplex Virus Consumption and Growth Rate (2017-2022)
-
Figure Global Adenovirus Consumption and Growth Rate (2017-2022)
-
Figure Global Non-viral Plasmid Vector Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Lymphoblastic Leukemia (ALL) Consumption and Growth Rate (2017-2022)
-
Figure Global Inherited Retinal Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Large B-cell Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global ADA-SCID Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma (Lesions) Consumption and Growth Rate (2017-2022)
-
Figure Global Beta-Thalassemia Major/SCD Consumption and Growth Rate (2017-2022)
-
Figure Global Head & Neck Squamous Cell Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Global Peripheral Arterial Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Spinal Muscular Atrophy (SMA) Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy Consumption by Country (2017-2022)
-
Table North America Gene Therapy Consumption by Country (2017-2022)
-
Figure United States Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Canada Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Mexico Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Gene Therapy Consumption by Country (2017-2022)
-
Figure Germany Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure UK Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Spain Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Belgium Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure France Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Italy Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Denmark Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Finland Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Norway Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Sweden Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Poland Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Russia Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Turkey Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table APAC Gene Therapy Consumption by Country (2017-2022)
-
Figure China Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Thailand Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Singapore Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Philippines Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table South America Gene Therapy Consumption by Country (2017-2022)
-
Figure Brazil Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Colombia Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Chile Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Argentina Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Peru Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table GCC Gene Therapy Consumption by Country (2017-2022)
-
Figure Bahrain Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Oman Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Qatar Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table Africa Gene Therapy Consumption by Country (2017-2022)
-
Figure Nigeria Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Africa Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Egypt Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Algeria Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table Oceania Gene Therapy Consumption by Country (2017-2022)
-
Figure Australia Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table Dimension Therapeutics Company Details
-
Table Dimension Therapeutics Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dimension Therapeutics Gene Therapy Main Business and Markets Served
-
Table Dimension Therapeutics Gene Therapy Product Portfolio
-
Table Celladon Company Details
-
Table Celladon Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celladon Gene Therapy Main Business and Markets Served
-
Table Celladon Gene Therapy Product Portfolio
-
Table Vical Company Details
-
Table Vical Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vical Gene Therapy Main Business and Markets Served
-
Table Vical Gene Therapy Product Portfolio
-
Table Avalanche Bio Company Details
-
Table Avalanche Bio Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Avalanche Bio Gene Therapy Main Business and Markets Served
-
Table Avalanche Bio Gene Therapy Product Portfolio
-
Table Spark Therapeutics Company Details
-
Table Spark Therapeutics Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spark Therapeutics Gene Therapy Main Business and Markets Served
-
Table Spark Therapeutics Gene Therapy Product Portfolio
-
Table Sangamo Company Details
-
Table Sangamo Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sangamo Gene Therapy Main Business and Markets Served
-
Table Sangamo Gene Therapy Product Portfolio
-
Table Advantagene Company Details
-
Table Advantagene Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advantagene Gene Therapy Main Business and Markets Served
-
Table Advantagene Gene Therapy Product Portfolio
-
Figure Global Lentivirus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AAV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retrovirus & Gammaretrovirus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Modified Herpes Simplex Virus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adenovirus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-viral Plasmid Vector Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute Lymphoblastic Leukemia (ALL) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inherited Retinal Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Large B-cell Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ADA-SCID Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma (Lesions) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Beta-Thalassemia Major/SCD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Head & Neck Squamous Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peripheral Arterial Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Spinal Muscular Atrophy (SMA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Therapy Consumption Forecast by Country (2022-2028)
-
Table North America Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure Germany Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure China Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure Brazil Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure Australia Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
